ScholarIQanswers from OpenAlex
PI3K/AKT/mTOR signaling in cancer
TopicLeading institutions, researchers & key papers
PI3K/AKT/mTOR signaling in cancer is a topic indexed in ScholarIQ from OpenAlex.
What is known about PI3K/AKT/mTOR signaling in cancer?
ScholarIQrecord summary
This cluster of papers focuses on the mTOR signaling pathway, particularly its role in growth control, metabolism, and disease, with a specific emphasis on cancer. The PI3K/AKT pathway, Raptor, TSC2, and rapamycin are central to the research discussed in these papers.
How many works does PI3K/AKT/mTOR signaling in cancer have?
ScholarIQindexed works
PI3K/AKT/mTOR signaling in cancer has 50,153 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does PI3K/AKT/mTOR signaling in cancer have?
ScholarIQcitation count
PI3K/AKT/mTOR signaling in cancer has 1,562,623 citations in the OpenAlex counts ScholarIQ stores.
What is the OpenAlex record for PI3K/AKT/mTOR signaling in cancer?
ScholarIQopenalex
The OpenAlex for PI3K/AKT/mTOR signaling in cancer is on the source record.
Who are the most-cited researchers behind PI3K/AKT/mTOR signaling in cancer?
ScholarIQtop researchers by citations
Where is PI3K/AKT/mTOR signaling in cancer research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
No journal data available yet.
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock